Alex Fagella

Cooley advised Thrasio, a consumer goods company, on its more than $1 billion Series D financing round, which brings the company’s total funding to more than $3.4 billion. Partner Adam Dinow led the Cooley team advising Thrasio.

Cooley advised AvePoint, the largest data management solutions provider for the Microsoft cloud, on its agreement to combine with Apex Technology Acquisition Corporation, a publicly traded special purpose acquisition company or SPAC. Partners David Silverman, John McKenna and Brian Leaf led the Cooley team advising AvePoint.

Cooley advised White Ops, a leader in bot mitigation, bot prevention and ad fraud prevention, on its sale to Goldman Sachs Merchant Banking Division, ClearSky Security, and Nightdragon. Lawyers Izzy Lubarsky, Eric Dixon, Alex Fagella, Tanisha James, Stephanie Gentile, Joshua Friedman and Joseph Lockinger led the Cooley team. 

Cooley advised H1 Insights, which provides a platform companies can use to find thought-leading healthcare professionals, on its $58 million Series B financing to curate a database of doctors around the world, providing a tool for pharmaceutical companies to find key opinion leaders, clinical trial market intelligence and rising stars in certain specialties. Cooley partner Jeff Laretto led the team advising H1 Insights.

Cooley advised Pharming Group on its direct listing of 899,802 American depositary shares. Pharming Group, whose shares are now listed on the Nasdaq Global Market under the symbol PHAR, also trades on Euronext Amsterdam Market under the symbol PHARM. Pharming Group is a commercial-stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. Partner David Boles, Eric Blanchard and David Boles led the Cooley team.